BRIEFLY NOTED: Canadian generic pharmaceutical company files second NAFTA claim against United States June 29, 2009News, North American Free Trade Agreement (NAFTA), UNCITRAL and Ad-Hoc Apotex arbitration, drug patent arbitration, generic pharmaceutical dispute, investment treaty arbitration, investment treaty intellectual property, investment treaty IP claims, IP arbitration, NAFTA arbitration, NAFTA Chapter 11 Luke Eric Peterson You are not logged in. If you are a subscriber, please Login to access. If you are not a subscriber, you can contact us for a rate quote at subscribe@iareporter.com. Alternatively, you can sign up to receive free email headlines here.